This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ducas, J. Articles by Prewitt, R. M. Search for Related Content PubMed PubMed Citation Articles by Ducas, J. Articles by Prewitt, R. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB HYDRALAZINE HYDROCHLORIDE Medline Plus Health Information Pulmonary Embolism

Circulation, Vol 73, 1050-1057, Copyright © 1986 by American Heart Association

ARTICLES

Pulmonary vascular effects of hydralazine in a canine preparation of pulmonary thromboembolism

J Ducas, L Girling, U Schick and RM Prewitt

Pulmonary arterial pressure (PAP)-flow coordinates were obtained in 14 anesthetized dogs before and after pulmonary hypertension was induced with autologous blood clots. Cardiac output (CO) was altered by systemic arteriovenous fistulas. The PAP-CO coordinates were always rectilinear. Before emboli, the mean vascular closing or outflow pressure (the pressure intercept of the PAP-CO line) was 8.8 +/- 2.1 (SD) mm Hg. Emboli increased PAP (15.1 +/- 1.6 to 36.5 +/- 3.5 mm Hg; p less than .001) and decreased CO (3.8 +/- 0.6 to 2.4 +/- 0.8 liters X min-1; p less than .001). Incremental resistance (the slope of the PAP- CO line) only increased slightly. On the other hand, the marked increase in PAP was predominantly due to an increase in effective outflow pressure (from 8.8 +/- 2.1 to 28.6 +/- 3.6; p less than .001). Hydralazine was administered in a dose sufficient to double CO. This did not affect PAP and caused an inconsistent and small decrease in incremental resistance. However, a consistently significant decrease in effective outflow pressure, averaging 23%, was observed. In this canine preparation of pulmonary hypertension the predominant effect of hydralazine appears to be a decrease in the mean vascular closing or outflow pressure.

This article has been cited by other articles:

				Y. M. Smulders Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction Cardiovasc Res, October 1, 2000; 48(1): 23 - 33. [Abstract] [Full Text] [PDF]

				B. Lambermont, P. Kolh, O. Detry, P. Gerard, R. Marcelle, and V. D'Orio Analysis of endotoxin effects on the intact pulmonary circulation Cardiovasc Res, January 1, 1999; 41(1): 275 - 281. [Abstract] [Full Text] [PDF]

				M. Maggiorini, S. Brimioulle, D. De Canniere, M. Delcroix, and R. Naeije Effects of pulmonary embolism on pulmonary vascular impedance in dogs and minipigs J Appl Physiol, March 1, 1998; 84(3): 815 - 821. [Abstract] [Full Text] [PDF]

				Shian Gu, R. M. Prewitt, U. Schick, and J. Ducas Effects of Progressive Vascular Occlusion on Slope and Intercept of the Pulmonary Artery Pressure-Flow Relationship Angiology, January 1, 1995; 46(1): 45 - 52. [Abstract] [PDF]